Drew Capurro is a partner in the Orange County office. He is a strategic advisor for his clients with a practice that focuses primarily on the representation of public and private companies, with deep experience in the life sciences, technology, homebuilder, and consumer retail industries. He also regularly represents investment banks in transactions with these companies.
Drew has a particular emphasis in public and private capital markets transactions and has represented issuers and underwriters in a broad range of matters, including:
Mister Car Wash in its US$647 million initial public offering
JOANN in its US$131 million initial public offering
PROCEPT BioRobotics in its US$188 million initial public offering and subsequent US$161 million follow-on offering
Winc in its initial public offering
Guardant Health in its US$273 million initial public offering and subsequent common stock and convertible note financings
Virgin Galactic in its business combination transaction with a special purpose acquisition company and subsequent common stock and convertible debt offerings
Ouster in its business combination transaction with a special purpose acquisition company and subsequent financing transactions and merger of equals with Velodyne
Offerpad in its business combination transaction with a special purpose acquisition company and subsequent equity financings
Owlet in its business combination transaction with a special purpose acquisition company and subsequent preferred stock financing
SciPlay in its US$352 million IPO
Switch in its US$611 million IPO
Boxed in its business combination transaction with a special purpose acquisition company and subsequent liquidity management transaction
Planet Labs in its business combination transaction with a special purpose acquisition company
GCM Grosvenor in its business combination transaction with a special purpose acquisition company
Advantage Solutions in its business combination transaction with a special purpose acquisition company
Virgin Orbit in its business combination transaction with a special purpose acquisition company
MultiSensor AI, a provider of intelligent thermal imaging platforms, in its business combination with a special purpose acquisition company.
AEON Biopharma, a clinical-stage biopharmaceutical company developing a proprietary botulinum toxin for the treatment of multiple debilitating medical conditions, in its business combination with a special purpose acquisition company
Drew also regularly advises private and public companies at all stages of maturity in strategic matters involving corporate governance, state and federal securities laws, fiduciary duties, employment and compensation, and Securities Exchange Act compliance and disclosure obligations.
Multidisciplinary team represents the NASDAQ-listed technology solutions provider at the intersection of robotics, sensors, software analytics, and connectivity in all-stock transaction.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.
